Abiopharma

🔍 Tsai Joseph C (Executive)

Company: Alibaba Group Holding Ltd (BABA)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 720,000 shares of Ordinary Shares at $14.47 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: false | shares_owned_after: 114,979,168.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-25 | Code: H | shares_owned_after: 825,238.00
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 1,280,000.00

Footnotes:

• F1: The sales prices reported herein were converted from Hong Kong dollars to United States dollars at a conversion price of HK$7.8412 to US$1.00.
• REMARKS: This report does not include ordinary shares held by Joe and Clara Tsai Foundation Limited and Parufam Limited, which were reported in the Issuer's annual report on Form 20-F. The Reporting Person disclaims any pecuniary interest in, or beneficial ownership over, such ordinary shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.